Tuesday, April 24, 2007 12:42:53 AM
With this acquisition, I think Balchem will become the primary choline (vitamin B4) producer in North America... Also, they just announced earlier this month that they would be purchasing Akzo's choline / methyl-amines business in Italy... thus vastly increasing their global market share of choline in just the past few weeks.
Good stuff. Good stuff indeed.
http://www.balchem.com/core/newsletter_details.asp?ArticleID=316
New Hampton, New York - March 19, 2007 - Balchem Corporation (NASDAQ: BCPC) today announced that its subsidiary, BCP Ingredients, Inc. acquired certain choline chloride business assets of Chinook Group Limited of Sombra, Ontario, Canada. Financial terms will be disclosed in SEC filings relating to the transaction.
The acquisition will be integrated into BCP Ingredients’ existing choline chloride manufacturing operations in Verona, Missouri and St. Gabriel, Louisiana. “We are excited at the prospect of enhancing our ability to service the animal nutrition marketplace from our strategically located facilities. Global market dynamics require suppliers to gain scale in order to effectively and economically produce and distribute quality product. Our focused efforts on choline will enable us to contribute to the development of efficient, high performance diets formulated by nutritional experts," said Balchem President and CEO, Dino Rossi. "This acquisition is one more building block in our growth strategy for the animal nutrition and health industry, and a wonderful opportunity for Balchem to implement, and for the consumer to realize, more fully, our synergies which are derived across multiple integrated business segments.”
Choline chloride is an essential nutrient for optimum animal growth, and is integral in building, regulating, and maintaining cell membrane integrity and porosity. It also acts as a lipotropic agent, which aids in the utilization and outward transport of fat in the liver. Choline and choline derivatives are also used in many other industrial applications.
Your trading and investment choices should be the result of your own due diligence.
Recent BCPC News
- Balchem Corporation Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- New York Jets Announce Multi-Year Partnership with VitaCholine® • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Balchem Corporation to Attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024 • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Balchem Corporation Releases 2023 Sustainability Report • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
- Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024 • GlobeNewswire Inc. • 04/19/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 11:18:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:30:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:32:14 PM
- Balchem Corporation to Participate at the BNP Paribas Exane 12th Consumer Ingredients Conference on March 14, 2024 • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:58:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 09:57:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:11:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:41:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:37:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 10:08:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 10:12:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 10:12:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 09:55:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/16/2024 10:26:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 12:14:27 PM
- Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/16/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 12:09:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:58:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:55:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:00:07 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM